BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 30447464)

  • 21. Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis.
    Stessin AM; Schwartz A; Judanin G; Pannullo SC; Boockvar JA; Schwartz TH; Stieg PE; Wernicke AG
    J Neurosurg; 2012 Oct; 117(4):669-75. PubMed ID: 22900840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
    Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
    Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
    Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
    J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
    Hemmati SM; Ghadjar P; GrĂ¼n A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
    Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control.
    Dohm A; McTyre ER; Chan MD; Fan C; Isom S; Bourland JD; Mott RT; Cramer CK; Tatter SB; Laxton AW
    J Clin Neurosci; 2017 Dec; 46():90-98. PubMed ID: 28917587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local control and overall survival in atypical meningioma: a retrospective study.
    Goyal LK; Suh JH; Mohan DS; Prayson RA; Lee J; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):57-61. PubMed ID: 10656373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
    Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
    Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
    Rubino F; Schur S; McGovern SL; Kamiya-Matsuoka C; DeMonte F; Raza SM
    J Neurosurg; 2023 Sep; 139(3):798-809. PubMed ID: 36738459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant radiotherapy for atypical meningiomas is associated with improved progression free survival.
    Unterberger A; Ng E; Pradhan A; Kondajji A; Kulinich D; Duong C; Yang I
    J Neurol Sci; 2021 Sep; 428():117590. PubMed ID: 34358821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
    Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
    J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
    Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
    J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant radiotherapy in grossly total resected grade II atypical meningiomas: a protective effect on recurrence?
    Zoli M; Della Pepa GM; Carretta A; Bongetta D; Somma T; Zoia C; Raffa G
    J Neurosurg Sci; 2022 Jun; 66(3):240-250. PubMed ID: 34763391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection.
    Sun SQ; Kim AH; Cai C; Murphy RK; DeWees T; Sylvester P; Dacey RG; Grubb RL; Rich KM; Zipfel GJ; Dowling JL; Leuthardt EC; Leonard JR; Evans J; Simpson JR; Robinson CG; Perrin RJ; Huang J; Chicoine MR
    Neurosurgery; 2014 Oct; 75(4):347-54; discussion 354-5; quiz 355. PubMed ID: 24932707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
    Aghi MK; Carter BS; Cosgrove GR; Ojemann RG; Amin-Hanjani S; Martuza RL; Curry WT; Barker FG
    Neurosurgery; 2009 Jan; 64(1):56-60; discussion 60. PubMed ID: 19145156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.
    Masalha W; Heiland DH; Franco P; Delev D; Haaker JG; Schnell O; Scheiwe C; Grauvogel J
    J Neurooncol; 2018 Jan; 136(1):147-154. PubMed ID: 29081038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of adjuvant radiotherapy in atypical meningioma.
    Park HJ; Kang HC; Kim IH; Park SH; Kim DG; Park CK; Paek SH; Jung HW
    J Neurooncol; 2013 Nov; 115(2):241-7. PubMed ID: 23949108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
    Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
    J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection.
    Sun SQ; Cai C; Murphy RK; DeWees T; Dacey RG; Grubb RL; Rich KM; Zipfel GJ; Dowling JL; Leuthardt EC; Leonard JR; Evans J; Simpson JR; Robinson CG; Perrin RJ; Huang J; Chicoine MR; Kim AH
    Neurosurgery; 2014 Oct; 75(4):356-63; discussion 363. PubMed ID: 24932708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
    Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
    J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy for atypical meningiomas.
    Mair R; Morris K; Scott I; Carroll TA
    J Neurosurg; 2011 Oct; 115(4):811-9. PubMed ID: 21699480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.